Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

India slaps reciprocal travel curbs on COVID-19 vaccinated UK nationals - source

Published 01/10/2021, 14:27
Updated 01/10/2021, 14:31

NEW DELHI (Reuters) - UK nationals visiting India this month will have to undergo mandatory quarantine even if they are fully vaccinated against COVID-19 in retaliation for UK curbs on Indian citizens, a senior government source in New Delhi said on Friday. The new rules, which take effect from Monday, follow the UK decision to require Indians vaccinated with AstraZeneca (NASDAQ:AZN)'s Covishield to quarantine.

India mainly relies on the Covishield vaccine, developed by AstraZeneca and manufactured in India by Pune-based Serum Institute, which is not recognised by Britain under new rules, despite being identical to the doses given to millions of Britons.

AstraZeneca is one of the key providers to Britain's vaccination program, along with U.S. peers Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE).

"India has decided to impose reciprocity on UK nationals arriving in India from the UK," the source said, declining to be identified in line with government policy.

Government sources in New Delhi had last month warned of retaliation after Foreign Minister Subrahmanyam Jaishankar said he had urged for an early resolution after a meeting with his British counterpart at the United Nations General Assembly in New York.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.